Royal DSM, the global Life Sciences and Materials Sciences Company, has won an appeal regarding the opposition of patent EP1232198, titled, UV Curable Compositions at the European Patent Office Board of Appeal in Munich, Germany on January 17, 2014. This patent, currently assigned to 3D Systems, Inc., was revoked at the European level, thus allowing for increased development of materials in this field.
DSM wins patent opposition appeal impacting stereolithography development
Royal DSM, the global Life Sciences and Materials Sciences Company, has won an appeal regarding the opposition of patent EP1232198, titled, UV Curable Compositions at the European Patent Office Board of Appeal in Munich, Germany on January 17, 2014.
By
Jim Woodcock
Published:
Last updated:
Tags:
Vat Photopolymerization
More in Vat Photopolymerization
See all
More from Jim Woodcock
See all
From our partners
Pushing the limits
How metal additive manufacturing is enabling Stoke Space to unlock the new space economy.
By
TCT Team
/
Advanced Composite Manufacturing for Next-Gen Defense and Aerospace Systems
Mil-Ready. ITAR-Ready. Built from Motorsport DNA.
By
TCT Team
/
Additive Screen Printing: Scalable production meets micro precision
Additive Screen Printing offers a scalable way to produce micro-precision parts while maintaining production speed.
By
TCT Team
/
Why real-time access to 3D measurement data is critical for accelerated manufacturing decisions
Frédéric Hébert, Vice President of Products and Innovation for the Collaborative Suite at InnovMetric, explains how engineers and QC leads would benefit from an upgraded data management solution.
/